Hua Ling

1.5k total citations
65 papers, 1.0k citations indexed

About

Hua Ling is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Obstetrics and Gynecology. According to data from OpenAlex, Hua Ling has authored 65 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cardiology and Cardiovascular Medicine, 13 papers in Molecular Biology and 13 papers in Obstetrics and Gynecology. Recurrent topics in Hua Ling's work include Pregnancy and preeclampsia studies (13 papers), Birth, Development, and Health (7 papers) and Lipoproteins and Cardiovascular Health (6 papers). Hua Ling is often cited by papers focused on Pregnancy and preeclampsia studies (13 papers), Birth, Development, and Health (7 papers) and Lipoproteins and Cardiovascular Health (6 papers). Hua Ling collaborates with scholars based in United States, China and United Kingdom. Hua Ling's co-authors include K. H. Nicolaides, Daniel E. Hilleman, Liona C. Poon, Nikos A. Kametas, Yuqi He, Martín Thomas, Suneil Aggarwal, Yanliu Lu, Adrian S. H. Cheng and Darlington O. Okonko and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Hua Ling

63 papers receiving 994 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hua Ling United States 19 279 181 176 156 152 65 1.0k
Mònica Tous Spain 22 105 0.4× 133 0.7× 178 1.0× 271 1.7× 170 1.1× 41 1.2k
Luis M. Beltrán Spain 16 111 0.4× 71 0.4× 198 1.1× 254 1.6× 143 0.9× 50 1.1k
Andrea Dalbeni Italy 18 226 0.8× 361 2.0× 181 1.0× 458 2.9× 145 1.0× 82 1.3k
Ajay P. Sharma Canada 20 103 0.4× 47 0.3× 137 0.8× 96 0.6× 125 0.8× 57 1.1k
Joost H.W. Rutten Netherlands 18 398 1.4× 83 0.5× 487 2.8× 262 1.7× 212 1.4× 46 1.5k
Minodora Dobreanu Romania 16 84 0.3× 43 0.2× 275 1.6× 161 1.0× 148 1.0× 93 885
Haixia Li China 17 73 0.3× 35 0.2× 258 1.5× 121 0.8× 114 0.8× 65 896
Ali Ramezani United States 16 119 0.4× 137 0.8× 935 5.3× 174 1.1× 122 0.8× 24 1.7k
Renyu Ding China 16 67 0.2× 54 0.3× 206 1.2× 266 1.7× 114 0.8× 39 869

Countries citing papers authored by Hua Ling

Since Specialization
Citations

This map shows the geographic impact of Hua Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hua Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hua Ling more than expected).

Fields of papers citing papers by Hua Ling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hua Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hua Ling. The network helps show where Hua Ling may publish in the future.

Co-authorship network of co-authors of Hua Ling

This figure shows the co-authorship network connecting the top 25 collaborators of Hua Ling. A scholar is included among the top collaborators of Hua Ling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hua Ling. Hua Ling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Miao, et al.. (2024). PPARα is one of the key targets for dendrobine to improve hepatic steatosis in NAFLD. Journal of Ethnopharmacology. 323. 117684–117684. 12 indexed citations
2.
Jiang, Yuan, Daopeng Tan, Yanliu Lu, et al.. (2022). Opposite trends of glycosides and alkaloids in Dendrobium nobile of different age based on UPLC‐Q/TOF‐MS combined with multivariate statistical analyses. Phytochemical Analysis. 33(4). 619–634. 19 indexed citations
3.
Teng, Fei, Songmei Wang, Hua Ling, et al.. (2022). Associations and pathways between residential greenness and hyperuricemia among adults in rural and urban China. Environmental Research. 215(Pt 2). 114406–114406. 8 indexed citations
4.
Ling, Hua, et al.. (2020). Maternal cardiac adaptation and fetal growth. American Journal of Obstetrics and Gynecology. 224(6). 601.e1–601.e18. 11 indexed citations
5.
Deb, Subrata, et al.. (2020). Assessing the Elevation of Cardiac Biomarkers and the Severity of COVID-19 Infection: A Meta-analysis. Journal of Pharmacy & Pharmaceutical Sciences. 23. 396–405. 22 indexed citations
8.
Ling, Hua, et al.. (2020). Clinical validation of bioreactance for the measurement of cardiac output in pregnancy. Anaesthesia. 75(10). 1307–1313. 9 indexed citations
9.
Ling, Hua, et al.. (2017). Effect of change in posture on maternal functional hemodynamics at 35–37 weeks' gestation. Ultrasound in Obstetrics and Gynecology. 51(3). 368–374. 7 indexed citations
10.
Xin, Ming, Fang Li, Chunli Zheng, et al.. (2016). Enhanced tumor delivery and antitumor response of doxorubicin loaded albumin nanoparticles formulated based on a Schiff base. International Journal of Nanomedicine. Volume 11. 3875–3890. 27 indexed citations
11.
Ling, Hua, et al.. (2016). Clinical efficacy and safety of evolocumab for low-density lipoprotein cholesterol reduction. Vascular Health and Risk Management. 12. 163–163. 13 indexed citations
12.
Ling, Hua, Julia Flint, Morten Damgaard, et al.. (2014). Calculated Plasma Volume Status and Prognosis in Chronic Heart Failure. European Journal of Heart Failure. 17(1). 35–43. 101 indexed citations
13.
Jabbour, Richard J., Hua Ling, Suneil Aggarwal, et al.. (2014). Serum albumin changes and multivariate dynamic risk modelling in chronic heart failure. International Journal of Cardiology. 176(2). 437–443. 23 indexed citations
14.
Wang, Jing, Cui He, Jenny H. Hsi, et al.. (2014). Virological Outcomes and Drug Resistance in Chinese Patients after 12 Months of 3TC-Based First-Line Antiretroviral Treatment, 2011–2012. PLoS ONE. 9(2). e88305–e88305. 19 indexed citations
15.
Ling, Hua, et al.. (2013). Impact of Ranolazine on Clinical Outcomes and Healthcare Resource Utilization in Patients with Refractory Angina Pectoris. American Journal of Cardiovascular Drugs. 13(6). 407–412. 7 indexed citations
17.
Wang, Xia, Cui He, Hui Xing, et al.. (2012). Short Communication: Emerging Transmitted HIV Type 1 Drug Resistance Mutations Among Patients Prior to Start of First-Line Antiretroviral Therapy in Middle and Low Prevalence Sites in China. AIDS Research and Human Retroviruses. 28(12). 1637–1639. 17 indexed citations
18.
Ling, Hua, Suneil Aggarwal, Julia Flint, et al.. (2011). Abstract 16398: Prognostic Utility of the Hemoglobin/Hematocrit Equation for Estimating Plasma Volume Changes Over Time in Chronic Heart Failure. Circulation. 124. 1 indexed citations
19.
Ling, Hua, Liangui Feng, Xianbin Ding, et al.. (2009). Human leukocyte antigen profile in HIV‐1 infected individuals and AIDS patients from Chongqing, China. Microbiology and Immunology. 53(9). 512–523. 6 indexed citations
20.
Ling, Hua, et al.. (2000). Evaluation of patient waiting times at an academic ophthalmology clinic.. PubMed. 15(5). 228–33. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026